[Federal Register: October 3, 2003 (Volume 68, Number 192)]
[Notices]               
[Page 57465-57466]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03oc03-82]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-76-03]

 
Proposed Data Collections Submitted for Public Comment and 
Recommendations

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 498-1210. Send written 
comments to CDC, Desk Officer, Human Resources and Housing Branch, New 
Executive Office Building, Room 10235, Washington, DC 20503 or by fax 
to (202) 395-6974. Written comments should be received within 30 days 
of this notice.
    Proposed Project: WISEWOMAN Reporting System--New--National Center 
for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers 
for Disease Control and Prevention (CDC).

Background

    The WISEWOMAN program, which focuses on reducing cardiovascular 
disease risk factors among at-risk women, was in response to the 
``Secretary of Health and Human Services Continuous Improvement 
Initiative'', asking for the development of programs that examine ways 
in which service delivery can be improved for select populations. Title 
XV of the Public Health Service Act, Section 1509 originally authorized 
the Secretary of the Department of Health and Human Services to 
establish up to three demonstration projects. Through appropriations 
language, the CDC WISEWOMAN program is now allowed to fund up to 15 
projects, although current plans includes 12 demonstration projects. At 
full implementation, the projects are expected to screen approximately 
30,000 women annually for cardiovascular disease risk factors. The 
program targets women already participating in the National Breast and 
Cervical Cancer Early Detection Program (NBCCEDP) and provides 
screening for select cardiovascular disease risk factors (including 
elevated cholesterol, hypertension, and abnormal blood glucose levels), 
lifestyle interventions, and medical referrals as required in an effort 
to improve cardiovascular health among participants.
    CDC proposes to collect and analyze baseline and follow-up data (12 
months post enrollment) for all participants. These data, called the 
minimum data elements (MDE's), includes demographic and risk factor 
information about women served in each program and information 
concerning the number and type of intervention sessions attended. The 
MDE data allows for an assessment of how effective WISEWOMAN is at 
reducing the burden of cardiovascular disease risk factors among 
participants. CDC also proposes to collect programmatic data for all 
WISEWOMAN programs. Programmatic data includes information related to 
grantee management, public education and outreach, professional 
education, service delivery, cost, and an assessment of how well each 
program is meeting their stated objectives.
    All required data will be submitted electronically to a contractor 
to conduct the WISEWOMAN evaluation. MDE and cost data will be 
submitted twice a year, October 15 and April 15. October 15 reporting 
will cover all MDE's and costs for activities that took place between 
January 1 and June 30, and the April 15 submission will cover MDE's and 
costs for activities occurring between July 1 and December 31. 
Quarterly reports containing programmatic data will be due to RTI on 
January 31 (reflecting October 1-December 31 program activities), April 
30 (reflecting January 1-March 31), July 31 (reflecting April 1-June 
30), and October 31 (reflecting July 1-September 30). All reports will 
be due in a pre-determined format provided by CDC and the contractor. 
The contractor will provide training as requested to WISEWOMAN 
personnel at each

[[Page 57466]]

location concerning data collection and submission.
    All information collected as part of the WISEWOMAN evaluation will 
be used to assess the costs, effectiveness, and cost-effectiveness of 
WISEWOMAN in reducing cardiovascular disease risk factors, for 
obtaining more complete health data among vulnerable populations, 
promoting public education of disease incidence and risk-factors, 
improving the availability of screening and diagnostic services for 
under-served women, ensuring the quality of services provided to women, 
and developing strategies for improved interventions. Because certain 
demographic data are already collected as part of NBCCEDP, the 
additional burden on grantees will be modest. Once the infrastructure 
is established to capture the additional WISEWOMAN data, the response 
burden is expected to be reduced even further. The annualized estimated 
burden for this data collection is 2,160 hours.

----------------------------------------------------------------------------------------------------------------
                                                                                Number of        Average burden
                          Form                               Number of        responses per    per response  (in
                                                            respondents         respondent           hours)
----------------------------------------------------------------------------------------------------------------
Screening MDE report...................................                 15                  2                 16
Intervention MDE report................................                 15                  2                  8
Cost report............................................                 15                  2                 16
Quarterly report.......................................                 15                  4                 16
----------------------------------------------------------------------------------------------------------------


    Dated: September 29, 2003.
Nancy E. Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 03-25086 Filed 10-2-03; 8:45 am]

BILLING CODE 4163-18-P